![Jong-Gil Shin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/09/2026
Jong-Gil Shin is currently the Chief Financial Officer, Director & Senior MD at Onconic Therapeutics, Inc. He holds an MBA from Tuck School of Business at Dartmouth.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 329.365 ( 0,73 % ) | 4 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCONIC THERAPEUTICS INC. | Director Financiero/CFO | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onconic Therapeutics Co., Ltd.
 Onconic Therapeutics Co., Ltd. BiotechnologyHealth Technology Operates as a drug discovery and development company which develops therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
